Novel Swan Pharma Limited
Manufacture of flat glass · Maesteg
ActiveUnited KingdomIncorporated 2021Private Limited Company
Financial position
Accounts to 2025-10-31 · GBP · Company accounts
Net assets
£107,225
Cash
—
Turnover
—
Profit / loss
—
Current assets
—
Creditors < 1 year
£1,534
Equity
—
Average employees
0
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2025-10-3112 months · Company | 2024-10-3112 months · Company | 2023-10-3112 months · Company | 2022-10-3112 months |
|---|---|---|---|---|
| Balance sheet | ||||
| Net assets | £107,225 | −£62,989 | −£54,279 | −£16,545 |
| Assets | ||||
| Fixed assets | £1,010,074 | £1,186,500 | £1,248,000 | £1,309,500 |
| Intangible assets | £0 | £1,086,500 | £1,148,000 | £1,209,500 |
| Property, plant & equipment | £100,000 | £100,000 | £100,000 | £100,000 |
| Current assets | — | — | — | £140,000 |
| Cash at bank | — | — | £36,339 | £0 |
| Debtors | £313,939 | £0 | — | £140,000 |
| Liabilities | ||||
| Creditors within one year | £1,534 | £1,534 | £1,500 | £0 |
| Creditors after one year | £1,215,254 | £1,247,955 | £1,337,118 | £1,466,045 |
| Net current assets | £312,405 | −£1,534 | £34,839 | £140,000 |
| Assets less current liabilities | £1,322,479 | £1,184,966 | £1,282,839 | £1,449,500 |
| People & pay | ||||
| Average employees | 0 | 0 | 0 | 0 |
| Source evidence | View filing | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
3 outstanding chargesAll Assets · created 2022-06-01
—
OutstandingFixed · created 2022-06-01
—
OutstandingAll Assets · created 2022-03-15
—
Outstanding